![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol. , 14 November 2023
Sec. Inflammation
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1327338
This article is a correction to:
Assessing the causal relationship between genetically determined inflammatory biomarkers and low back pain risk: a bidirectional two-sample Mendelian randomization study
by Li W, Lu Q, Qian J, Feng Y, Luo J, Luo C, He W, Dong B, Liu H, Liu Z and Su C (2023) Front. Immunol. 14:1174656. doi: 10.3389/fimmu.2023.1174656
In the published article, there was an error in affiliation 1. Instead of “Tui-Na department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China”, it should be “Tui-Na Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: inflammatory biomarkers, low back pain, Mendelian randomization, causality, interleukin 6 (IL-6)
Citation: Li W, Lu Q, Qian J, Feng Y, Luo J, Luo C, He W, Dong B, Liu H, Liu Z and Su C (2023) Corrigendum: Assessing the causal relationship between genetically determined inflammatory biomarkers and low back pain risk: a bidirectional two-sample Mendelian randomization study. Front. Immunol. 14:1327338. doi: 10.3389/fimmu.2023.1327338
Received: 24 October 2023; Accepted: 08 November 2023;
Published: 14 November 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Li, Lu, Qian, Feng, Luo, Luo, He, Dong, Liu, Liu and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chengguo Su, c3VjaGVuZ2d1bzE5ODQwODA0QDEyNi5jb20=; Zhongxing Liu, MTU5MzEyMzVAcXEuY29t; Huahui Liu, NDQyMTIxNjQ0QHFxLmNvbQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.